CareCloud (CCLD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
CareCloud (CCLD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
CareCloud, Inc. (NASDAQ:CCLD ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - CEO Stephen Snyder - President Norman Roth - Interim CFO and Corporate Controller Conference Call Participants Allen Klee - Maxim Group Operator Ladies and gentlemen, welcome to the CareCloud Second Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.
CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to loss of $0.37 per share a year ago.
Here is how CareCloud, Inc. (CCLD) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.
Here is how CareCloud, Inc. (CCLD) and Context Therapeutics Inc. (CNTX) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CareCloud (CCLD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
CareCloud (CCLD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how CareCloud, Inc. (CCLD) and Heron Therapeutics (HRTX) have performed compared to their sector so far this year.